Yatırımcı.AI

TRILC vs ECILC Comparison

Price, market cap, valuation, profitability and leverage metrics of TRILC and ECILC side by side.

TRILCECILC
StockFund

If you had invested TRY 10,000

Metric comparison

TRILC vs ECILC Comparison
MetricTRILCECILCSector median
Last price (TL)0.9164.5518.72
Daily change1.11%−5.77%−4.63%
Market capTRY 943.7MTRY 44.2BTRY 4.4B
P/B0.470.681.14
Dividend yield—2.04%0.90%
Return on equity−4.59%−3.08%1.78%
Free float73.16%22.02%37.21%
Ratios are calculated from the latest published financial statements.

Popular comparisons

Related pages

About the TRILC vs ECILC comparison

Price, market cap, valuation multiples, profitability and leverage of TRILC (Türk İlaç Serum) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 10:00. Of the 15 metrics compared, TRILC leads in 7 and ECILC leads in 8.

Highlights: Daily change: TRILC leads (1.11% vs −5.77%). Market cap: ECILC leads (TRY 44.2B vs TRY 943.7M). P/B: TRILC leads (0.47 vs 0.68). EV/EBITDA: TRILC leads (3.67 vs 165.19). EV/Sales: TRILC leads (3.61 vs 9.35). Gross margin: ECILC leads (37.83% vs 25.29%). EBITDA margin (annual): TRILC leads (27.80% vs 11.49%). Net margin (annual): TRILC leads (−1.65% vs −20.86%).

Frequently asked questions

By P/E, Tie is cheaper (— vs —); by P/B, TRILC trades at the lower multiple (0.47 vs 0.68).

Annual net margin is −1.65% for TRILC and −20.86% for ECILC; return on equity is −4.59% for TRILC and −3.08% for ECILC.

The leverage ratio is 76.53 for TRILC and 18.92 for ECILC; net debt/EBITDA is 2.88 for TRILC and 1.37 for ECILC. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.